PPT-"Creating a Prostate Cancer Center of Excellence"

Paul Sieber MD FACS Lancaster Urology ADT Clinic Why 1 Consistency of care 2 Improved outcomes 3 Better economics What does it take 1 Discipline. Matthew D. Katz, M.D.. Assistant Professor. Urologic Oncology . Robotic and Laparoscopic Surgery. University of Arkansas for Medical Sciences. Winthrop P. Rockefeller Cancer Center. Anatomy Genitourinary System. Norm D. Smith, M.D.. Associate Professor. Co-Director. Urologic Oncology. University of Chicago. United States Preventive Services Task Force (USPSTF). USPSTF Warns Against Blood Test For Prostate Cancer. . Julian Mander . RPH Urology. need. to know about . Prostate . C. ancer . Brian McGarry’s . S. tory. 1/30/2014 . To: DCS Faculty . From: Brian . McGarry. Patty . and I received news in the last couple weeks that I have inoperable prostate cancer that has spread to the bones and lymph glands. The last two weeks have been quite emotional for us. The irony is that I feel great and have no overt symptoms. But all the tests have confirmed this diagnosis and we are devastated.. This program will include a discussion of investigational agents not approved by the FDA for use in the United States, and data that were presented in abstract form. These data should be considered preliminary until published in a . The second most common cancer diagnosed in men. The incidence increase with age very rare before age of 40, more in western countries particularly Scandinavian countries (low light exposure), and black men are at greatest risk. The prostate is a gland the size of a walnut it sits at the neck of the bladder. Only men have a prostate gland!. Prostate cancer is the commonest type of male cancer . By far the biggest risk factor is age . 1. Global Burden of Disease Cancer Collaboration, Fitzmaurice C, et al. JAMA . Oncol. . 2015; 1(4): 505-27/ 2. . Droz. JP, et al. Lancet . Oncol. . 2014; 15(9): e404-14/ 3. . Cuzick. J, et al. Lancet . If you decide not to get screened, you can always change your mind later. If you decide to get screened, it does not mean you have to go to the next step. You should discuss each step with your docto Prostate and Cervical Cancer. . ostomies, . Microvascular Free Flap Assessment and . Learning Objectives. :. Describe the role of brachytherapy in the management of prostate cancer and cervical cancer. Sorting Out the Androgen Deprivation Therapy Options for Locally Advanced . CSPC. Supported by an educational grant from Astellas and Pfizer, Inc.. EPISODE 3. Cora N. Sternberg MD, FACP. Clinical Director, . Latest developments. . Prof.. . Neeraj Agarwal, MD. Director, Genitourinary Oncology Program, . Huntsman Cancer Institute, University of Utah, USA. MARCH 2022. PARPi. , poly-ADP ribose polymerase inhibitors. Victoria . Sinibaldi. , RN, MS, CS, CANP, BC. Daniel P . Petrylak. , MD. . Disclosures for . Ms. . Sinibaldi. No financial interests or affiliations to disclose. Disclosures for Dr . Petrylak. Consulting Agreements. Dr Marie-Pier St-Laurent, MD, FRCSC. Urologic-Oncology fellow, UBC. Research scientist, Vancouver Prostate Centre. Honorarium: Bayer, PCSC. As a urologist, I am biased towards prostate cancer screening..